COVID-19 in patients with bronchial asthma in International Clinic 2020- 2021. Number of cases

Abstract

Background: The confluence of asthma, an important and prevalent chronic respiratory disease, sometimes disabling, associated with COVID-19, the worst of recent pathologies, of global and acute presentation, has generated clinical situations not yet well established, reporting wide variability since asymptomatic to acute respiratory failure and death. Faced with the question of whether asthma represents a risk factor for the severity of COVID19 in our reality, we obtained information in our institution. Objective: To describe clinical and epidemiological characteristics of COVID-19 in a case series of patients with asthma in Clinic Internacional in 2020-2021. Methods: Observational, descriptive, retrospective research of 55 cases with asthma regularly seen in the medical office with COVID-19 confirmed. Data were obtained from survey and review of the clinical history. We analyzed using SPSS.25, with a significance level of 95%. Results: 60% of patients were women and the median was 44 years old. 72.7% were overweight or obese and 34.5% had asthma exacerbation. 83.6% had mild COVID-19, 9.1% moderate and 7.3% severe; reporting 69.1% pneumonia, 52.9% were hospitalized of them. 78.2% had well-controlled asthma and mild COVID-19 (p=0.317). 49.1% of patients with mild COVID-19 had intermittent or mild persistent asthma (p=0.515). Association was found between BMI and COVID-19 severity (p=0.028). Conclusions: It wasn’t association between the COVID-19’s severity with the control’s level and/or severity of asthma; but it exists with BMI, in the population studied.